Abstract. Antigen-evoked influx of extracellular Ca 2 ϩ into mast cells may occur via store-operated Ca 2 ϩ channels called calcium release-activated calcium (CRAC) channels. In mast cells of the rat basophilic leukemia cell line (RBL-2H3), cholera toxin (CT) potentiates antigen-driven uptake of 45 Ca 2 ϩ through cAMP-independent means. Here, we have used perforated patch clamp recording at physiological temperature to test whether cholera toxin or its substrate, Gs, directly modulates the activity of CRAC channels. Cholera toxin dramatically amplified (two-to fourfold) the Ca 2 ϩ release-activated Ca 2 ϩ current (I CRAC ) elicited by suboptimal concentrations of antigen, without itself inducing I CRAC , and this enhancement was not mimicked by cAMP elevation. In contrast, cholera toxin did not affect the induction of I CRAC by thapsigargin, an inhibitor of organelle Ca 2 ϩ pumps, or by intracellular dialysis with low Ca 2 ϩ pipette solutions. Thus, the activity of CRAC channels is not directly controlled by cholera toxin or Gs ␣ . Nor was the potentiation of I CRAC due to enhancement of phosphoinositide hydrolysis or calcium release. Because Gs and the A subunit of cholera toxin bind to ADP ribosylation factor (ARF) and could modulate its activity, we tested the sensitivity of antigen-evoked I CRAC to brefeldin A, an inhibitor of ARFdependent functions, including vesicle transport. Brefeldin A blocked the enhancement of antigenevoked I CRAC without inhibiting ADP ribosylation of Gs ␣ , but it did not affect I CRAC induced by suboptimal antigen or by thapsigargin. These data provide new evidence that CRAC channels are a major route for Fc ⑀ receptor I-triggered Ca 2 ϩ influx, and they suggest that ARF may modulate the induction of I CRAC by antigen.
Introduction
Calcium influx is thought to be required for the secretion of inflammatory mediators, activation of transcription factors, and the elaboration of cytokines by rat mast cells stimulated through the high affinity receptor (Fc ⑀ RI) for IgE. Cholera toxin (CT) 1 markedly potentiates Fc ⑀ RImediated uptake of 45 Ca 2 ϩ (Narasimhan et al., 1988 ) and secretion of preformed mediators (McCloskey, 1988; Narasimhan et al., 1988) by rat basophilic leukemia cell line (RBL-2H3) mast cells. The mechanisms by which Ca 2 ϩ uptake and secretion are enhanced remain unknown.
It is possible that the CT substrate, Gs, regulates Ca 2 ϩ entry by direct interaction with the presumed Fc ⑀ RI-activated Ca 2 ϩ channel, as is thought to occur with voltagegated Ca 2 ϩ channels in skeletal muscle (Hamilton et al., 1991) . CT also might act indirectly by enhancing the driving force on Ca 2 ϩ influx via membrane hyperpolarization. Here, we test these hypotheses using perforated patch clamp recording at physiological temperature from intact RBL-2H3 cells (Zhang and McCloskey, 1995) .
Experiments using radiotracer flux, Ca 2 ϩ -sensing fluorescent dyes, and patch clamping suggest that Fc ⑀ RI-mediated Ca 2 ϩ influx in RBL-2H3 mast cells may occur largely by so-called store-operated or capacitative calcium entry (Ali et al., 1994; McCloskey, 1999) . According to this scheme, conceived by James Putney to account for inositol trisphosphate (InsP 3 )-induced Ca 2 ϩ influx in exocrine cells, depletion of lumenal Ca 2 ϩ from the ER activates a Ca 2 ϩ entry pathway in the plasma membrane (Putney, 1986 (Putney, , 1990 . Calcium currents associated with this pathway were first observed in Jurkat human T cells and rat peritoneal mast cells, in which they are called Ca 2 ϩ release-acti-vated calcium currents, or I CRAC (Lewis and Cahalan, 1989; Hoth and Penner, 1992; Zweifach and Lewis, 1993) . Ca 2 ϩ store depletion is now known to elicit Ca 2 ϩ influx currents superficially related to I CRAC in a variety of cell types (for reviews see Fasolato et al., 1994; Berridge, 1995; Fanger et al., 1995) .
The mechanism that links Ca 2 ϩ store depletion to Ca 2 ϩ influx via calcium release-activated calcium (CRAC) channels has yet to be determined, and we do not address this issue here. A separate, unanswered question is whether I CRAC can be elicited or amplified through means other than Ca 2 ϩ store depletion. That CT enhances antigenevoked 45 Ca 2 ϩ uptake into RBL-2H3 cells might suggest a role for the toxin substrate, Gs, in regulation of store-operated Ca 2 ϩ influx. This trimeric GTP-binding protein regulates Ca 2 ϩ transport in a number of different systems, through means in addition to cAMP-dependent phosphorylation. In skeletal and cardiac muscle cells, for example, direct binding of Gs ␣ -GTP to voltage-gated Ca 2 ϩ channels is thought to increase the channel's open probability (Yatani et al., 1987; Hamilton et al., 1991) . Several other findings point to a more general involvement of Gs in cAMPindependent regulation of Ca 2 ϩ and/or Mg 2 ϩ transport across the plasma membrane (Maguire and Erdos, 1980; Murphy and McDermott, 1992; Scamps et al., 1992; Jouneaux et al., 1993) . With this precedent, it is relevant to ask whether the potentiation of antigen-evoked 45 
Ca
2 ϩ influx by CT involves direct modulation of presumed CRAC channels by the toxin or its substrate, Gs ␣ .
We found that CT markedly enhanced Fc ⑀ RI-induced Ca 2 ϩ currents in RBL-2H3 cells by a mechanism that is largely independent of cAMP. CT did not affect the induction of I CRAC by Ca 2 ϩ store depletion, per se. The enhancement of antigen-evoked I CRAC was not an indirect effect of membrane hyperpolarization, nor was it a direct effect of the toxin or Gs on CRAC channel properties. Rather, CT appeared to potentiate I CRAC by modulating an upstream signal other than phosphoinositide hydrolysis or Ca 2 ϩ release. The brefeldin A (BFA)-sensitivity of this step suggests the involvement of an ADP ribosylation factor (ARF) in the induction of I CRAC via the Fc ⑀ RI.
Materials and Methods

Reagents
Cholera holotoxin was from List Biological Laboratories. S-p-adenosine-3 Ј ,5 Ј -cyclic monophosphorothioate (Sp-cAMPS) was from Biomol Research Laboratories, Inc. BFA, EGTA, dibutyryl adenosine-3 Ј ,5 Ј -cyclic monophosphate, methylsulfoxide, nystatin, probenecid, and thapsigargin were from Sigma Chemical Co. Myo-[2 3 H]inositol (18 Ci/mmol) was from Amersham Life Sciences. 1,2-bis-(2-aminophenoxy)ethane-N,N,N Ј ,N Ј -tetraacetic acid (BAPTA) free acid was from Molecular Probes. BFA was used at a final concentration of 2 g/ml, obtained by diluting 1,000-fold into growth medium a 2-mg/ml stock solution in methylsulfoxide. Thapsigargin was diluted 500-fold into external buffer (see below) from methylsulfoxide stock solutions of appropriate thapsigargin concentration. Nystatin stock solutions (50 mg/ml) in methylsulfoxide were made fresh each day. All tissue culture reagents were from GIBCO BRL. Trinitrophenylated BSA (TNP-BSA) containing ‫ف‬ 15 mol TNP per mol BSA was synthesized as described (McCloskey, 1993) .
Cell Culture
The rat basophilic leukemia (RBL-2H3) cell line (Barsumian et al., 1981) was obtained from Dr. Reuben Siraganian (National Institutes of Health, Bethesda, MD) and grown for up to 30 passages before starting fresh cultures from frozen cell suspensions. Monolayer cultures were maintained at 37 Њ C, 5% CO 2 in MEM (Earle's salts) containing 15% heat-inactivated FBS, 100 U/ml penicillin, and 100 g/ml streptomycin sulfate. Stock cultures were passaged by trypsinization at 4-d intervals. In two sets of experiments, Ca 2 ϩ currents were measured in RBL-2H3 cells obtained from the American Type Culture Collection. Ca 2 ϩ currents in these cells were larger than others measured in this study, whether measured at 5-or the usual 4-d postpassage. Cells harvested from stock cultures were seeded onto 12-mm round glass coverslips contained in 24-well plates (8 ϫ 10 4 cells/well) and grown for 12-18 h in medium containing IgE before patch clamping. Monoclonal anti-TNP IgE, IGEL a2, (Rudolph et al., 1981) (TIB 142; American Type Culture Collection) partially purified from ascites was added to the culture medium at a protein concentration of 12 g/ ml. Just before the experiment, coverslips were rinsed in normal Ringer (see below) and placed into a recording chamber.
Electrical Recording
Except where noted otherwise, all experiments were conducted on intact cells using nystatin perforated patch recording (Horn and Marty, 1988) . Methods used for conventional and perforated patch whole cell recording were as described previously (Fan and McCloskey, 1994; Zhang and McCloskey, 1995) . Nystatin was used at a final concentration of 250 g/ml, produced by a 200-fold dilution of a 50-mg/ml solution (in methylsufulfoxide) into pipette solution. All experiments were conducted at 37 Њ C, using a Peltier device to warm the sample (Medical Systems Corp.). For most experiments, cells were voltage-clamped at a holding potential of 0 mV, and voltage ramp stimuli ( Ϫ 100 to ϩ 50 mV, 0.64 mV/ms) applied at 10-s intervals. A 140-ms conditioning pulse to Ϫ 100 mV was applied before each ramp, in part to prevent rapid inactivation during the ramp from distorting the shape of the current-voltage ( I-V ) curve (Zhang and McCloskey, 1995) . The Ca 2 ϩ current induced by antigen during perforated patch recording decays more rapidly than does that elicited by thapsigargin or by high concentrations of intracellular BAPTA; hereafter, I Ca refers to the peak Ca 2 ϩ current measured at Ϫ 80 mV. Micropipettes were pulled from Accu-fill 90 Micropets (B-D) and heat polished to resistances of 2-4 M ⍀ when filled with cesium glutamate (see below).
Conductances induced by antigen or thapsigargin were determined by computer subtraction of average traces acquired before from those taken after induction of inward Ca 2ϩ currents. This method was verified on a few cells by Ca 2ϩ removal, which eliminated the inward current in standard tetraethylammonium (TEA) aspartate (see below). Due to the rapidity of induction by cytoplasmic BAPTA, I-V plots in these experiments were determined by subtraction of traces in 0 mM extracellular Ca 2ϩ from those taken in 10 mM extracellular Ca 2ϩ . The experimental averages include cells from experiments conducted on multiple days. To minimize systematic errors, on each day we assayed at least three control cells and three cells from each treatment, where up to three treatments were carried out each day. All experimental values in this paper are presented as the average Ϯ SEM, and statistical significance was determined using the t test. Differences were considered significant if P Ͻ 0.05, and all differences listed were significant unless stated otherwise.
Solutions Used for Electrical Recording
For perforated patch recording, the pipette solution contained 55 mM KCl, 70 mM K 2 SO 4 , 7 mM MgCl 2 , 5 mM glucose, and 10 mM Hepes, pH 7.35. The Cs glutamate pipette solution used for conventional whole cell recording contained 150 mM glutamic acid, 8 mM NaCl, 10 mM BAPTA (H ϩ ) 4 , 2.0 mM CaCl 2 , 1.0 mM MgCl 2 , 0.5 mM MgATP, and 10 mM Hepes titrated to pH 7.20 with CsOH; the estimated free Ca 2ϩ concentration in this solution was ‫03ف‬ nM. The standard bath solution was TEA aspartate, which contained 10 mM CaCl 2 , 1 mM MgCl 2 , 88 mM NaOH, 152.5 mM aspartic acid, 64.5 mM tetraethylammonium hydroxide, 5.6 mM glucose, and 5 mM Hepes titrated to pH 7.4 with TEA hydroxide. This composition was chosen to eliminate outward Cl Ϫ and inward K ϩ currents, and to antagonize outward K ϩ currents with tetraethylammonium ion. 
P]ADP Ribosylation
ADP ribosylation was carried out as described previously (McCloskey, 1988) , except that reactions were terminated by addition of 1 ml ice cold 10 mM Hepes, pH 7.3, 135 mM NaCl and the membranes pelleted by centrifugation for 10 min at 20,000 g. Radioactive bands in the dried gels were imaged and digitized using a PhosphorImager, the image labeled in Adobe Photoshop, and printed by photomechanical transfer.
[
H]inositol Phosphates Production
Antigen-stimulated production of inositol phosphates was assayed on cell monolayers as described previously (Beaven et al., 1984) , with the following modifications. Cells were grown in three dram glass shell vials for 16-24 h before assay. Each vial was seeded with 2 ϫ 10 5 cells in 0.5 ml medium containing 1.5 g/ml anti-TNP IgE and 2 Ci/ml myo-[ 3 H]inositol (18 Ci/mmol). The growth medium was as described above but containing 1 rather than 15% FBS.
Calcium Imaging
Digital imaging of fura-2 loaded mast cells was carried out essentially as described for J774 monocytes (Fan and McCloskey, 1994) , except that cells were imaged at 33-34ЊC rather than room temperature. Cells were cultured overnight under the same conditions used for setting up the patch clamp experiments, loaded with 1 M fura-2 AM for 30 min at 37ЊC, rinsed, and incubated for another 30 min at 37ЊC before imaging in a Ca 2ϩ -free external buffer containing 135 mM NaCl, 5 mM KCl, 2 mM MgCl 2 , 5.6 mM glucose, 2.5 mM probenecid, 1 mM EGTA, and 10 mM Hepes, pH 7.4. The Ca 2ϩ signal from individual RBL-2H3 cells exhibits variable lag phases after antigen addition (Millard et al., 1988) . To eliminate this variability analytically, we used an Excel program which detects the first time point at which F 340 /F 380 crosses an arbitrarily set threshold, in this series of experiments defined as two SDs above the average resting F 340 /F 380 before antigen addition. These points were then aligned for each cell and the average time course of F 340 /F 380 calculated for the cells within the field of view.
Results
Enhancement of Antigen-induced Inward Current by CT
As observed previously (Zhang and McCloskey, 1995) , addition of 50 ng/ml TNP-BSA to anti-TNP IgE-sensitized cells induced an inwardly rectifying current with a time-topeak of 124 Ϯ 70 s ‫131ف(‬ Ϯ 9 s in the previous study). Decrease in antigen concentration lengthened the induction, the time-to-peak being ‫002ف‬ s at 5 ng/ml and 255 s at 1 ng/ml TNP-BSA. After reaching a peak, the current normally decayed substantially within several minutes, this presumably reflecting in part the refilling of intracellular Ca 2ϩ stores (Zweifach and Lewis, 1995) . Fig. 1 A shows a series of I-V curves for the inward current induced by different concentrations of antigen. Each curve represents the average of measurements on multiple cells (see legend). Fig. 1 B gives the peak inward current measured at Ϫ80 mV as a function of antigen concentration. A graded increase in magnitude of the induced current was observed up to concentrations of TNP-BSA ‫005ف‬ ng/ml, above which the response was saturated. At 50 ng/ml, TNP-BSA induced a peak current at Ϫ80 mV of Ϫ19.1 Ϯ 2.8 pA (n ϭ 16), similar to the value of I Ca induced by 50 ng/ml TNP-BSA in a previous study (Ϫ25.7 Ϯ 4.7 pA) that employed the same antibody-antigen combination (IGEL a2 anti-TNP IgE and TNP 15 -BSA).
As indicated in Fig. 1 B, pretreatment of RBL-2H3 cells with cholera holotoxin potentiated the inward current induced by subsequent exposure to antigen. In these experiments CT was applied at a concentration (2 g/ml) and for a time (1.5-2.5 h) shown previously to maximally enhance antigen-elicited 45 Ca 2ϩ uptake and secretion by RBL-2H3 cells (McCloskey, 1988; Narasimhan et al., 1988) . Potentiation of the inward current was dependent upon antigen concentration, being quite strong at low antigen concentration and insignificant at an antigen concentration sufficient to saturate the induction. At a concentration of 1 ng/ml, control cells exhibited an average current at Ϫ80 mV of ‫ف‬Ϫ9 pA, and CT pretreatment nearly tripled this to a value of ‫ف‬Ϫ24 pA, when all measurements are lumped in the averages. Table I summarizes the results of paired experiments conducted on different days (n ϭ 2-23), where the enhancement each day was calculated from the average of three to six control and three to six CT-treated cells. Note that CT enhanced by nearly threefold the inward current induced by 1 ng/ml TNP-BSA, whereas the current induced by TNP-BSA at 500 ng/ml was not enhanced by CT. From these observations it appears that CT might amplify a step in the normal induction process that operates with submaximal efficiency at concentrations of TNP-BSA Ͻ500 ng/ml. Between 50 and 500 ng/ml TNP-BSA, this step has reached maximal efficiency, and potentiation by CT is not observed.
Properties of CT-enhanced Ca 2ϩ Current
The ionic current elicited by antigen in CT-treated cells shared several features with that induced by antigen in control cells. For the sake of comparison, in Fig. 2 A we show average I-V plots obtained from 12 control and 8 CT-treated cells, each stimulated with 1 ng/ml TNP-BSA. Fig. 2 B gives average I-V plots obtained from 45 control and 33 CT-treated cells stimulated with 5 ng/ml TNP-BSA. The first point of similarity between the control and CTenhanced currents is that the shape of their I-V curves was inwardly rectifying. In both cases the induced current had a highly positive reversal potential consistent with Ca 2ϩ selectivity, and in fact Ca 2ϩ is the only major permeant ion present in the TEA aspartate bath solution with such a high reversal potential. Moreover, removal of Ca 2ϩ from the bath eliminated the inward current induced by antigen (data not shown). Fig. 3 A shows the result of an ion substitution experiment carried out on a CT-treated cell. Note that the antigen-induced current was carried effectively by barium ions, and that the shape of the Ba 2ϩ I-V plot was more steeply rectifying than the Ca 2ϩ I-V plot. This behavior was demonstrated previously for I CRAC in RBL-2H3 cells, whether I CRAC was elicited by antigen (Zhang and McCloskey, 1995) or induced by intracellular dialysis with a solution buffered at very low free Ca 2ϩ (Hoth, 1995) . Together, these observations suggest that CT amplifies the same Ca 2ϩ current (I CRAC ) as that activated by antigen alone.
The Ca 2ϩ current through CRAC channels inactivates on two different time scales. Rapid but partial inactivation occurs after step changes of membrane potential from 0 mV to hyperpolarized voltages Zhang and McCloskey, 1995) . Recovery from such voltage-dependent inactivation is complete within 2 s or less of returning the potential to 0 mV. Fig. 3 B shows average traces of normalized membrane current obtained from three control and three CT-pretreated cells, in each of which the Ca 2ϩ current was induced by 5 ng/ml TNP-BSA. In control cells, the Ca 2ϩ current inactivated by 56 Ϯ 6% (n ϭ 3) within 100 ms of step hyperpolarization from 0 to Ϫ100 mV. This level of steady-state inactivation is essentially equal to that reported for the Ca 2ϩ current induced by 50 ng/ml TNP-BSA, i.e., a 10-fold higher level of antigen (Zhang and McCloskey, 1995) . The antigen-induced current inactivated to a similar extent (62 Ϯ 6%; n ϭ 3) in CT-treated cells, a further point of similarity between the control and CT-enhanced Ca 2ϩ currents. Moreover, this demonstrates that the enhancement of I Ca by CT was not due to reduced voltage-dependent inactivation. That is, because I Ca was measured from I-V plots obtained by ramp stimulation after a 140-ms conditioning pulse to Ϫ100 mV, if the extent of inactivation during this prepulse was less in CT-treated than in control cells, then the value of I Ca would be greater in the CT-treated than in control cells. Clearly, the potentiation of I Ca by CT was not due to diminished voltage-dependent inactivation in CT-treated cells.
In principle, the magnitude of the peak Ca 2ϩ current might reflect a balance between rates of activation and slow inactivation (Zweifach and Lewis, 1995) . If so, CT could increase the peak I Ca by enhancing the rate of activation or reducing the rate of slow inactivation. But an increased rate of activation or a decreased rate of inactivation should reduce the average time-to-peak. The average time-to-peak was about the same in control and CTtreated cells. For example, at 5 ng/ml of TNP-BSA the average time-to-peak was 205 Ϯ 29 s (n ϭ 27) in control and 238 Ϯ 24 s (n ϭ 25) in CT-treated cells, an insignificant difference. That CT did not reduce the time-to-peak suggests that alteration of activation or inactivation rates does not cause the marked enhancement of I Ca .
We can also exclude the possibility that the large enhancement of Ca 2ϩ influx currents by CT resulted from the induction of I Ca by CT itself. As noted in Materials and Methods, the I-V curves shown in Figs. 2 and 3, as well as others used to derive the data shown in Fig. 1 and Table I , were obtained by computer subtraction of averaged traces taken before antigen addition. Thus, the measured currents did not contain any contribution from I Ca that might have been induced by pretreatment with CT alone. It is still relevant to ask whether CT treatment, per se, induced I Ca . If it did, then by the time electrical recording was begun, the magnitude of any induced Ca 2ϩ current was minuscule, much smaller than the extra ‫51ف‬ pA of current observed at 1 or 5 ng/ml TNP-BSA ( Fig. 1 and Table I ). Thus, a difference I-V plot of average ramp currents obtained from 35 control cells subtracted from 20 CT-treated cells-all recorded before exposure to antigen-was linear through the origin (data not shown). The slope reflects a very small increase in nonspecific leak conductance in the CT-treated cells (Ͻ1 pA at Ϫ80 mV), rather than the induction of I CRAC by CT. The large enhancement of antigen-induced I Ca by CT was not caused by antigen-independent induction.
Induction of I Ca Is Not Enhanced by Elevation of cAMP
CT elevates cAMP levels in RBL-2H3 cells (McCloskey, 1988; Narasimhan et al., 1988) , presumably through ADP ribosylation of Gs and activation of adenylyl cylcase. If the enhancement of I Ca by CT is due to chronic elevation of cAMP, then cell-permeant cAMP mimetics should reproduce the effect of the toxin. To test this idea, cells were preincubated for 1.5-3 h with the cell-permeant and phosphatase-resistant cAMP analogue, Sp-cAMPS (100 M), and then permeabilized and subjected to voltage-clamp recording in the presence of this compound. Treatment with Sp-cAMPS caused a modest but statistically insignificant increase in antigen-elicited inward Ca 2ϩ current, considerably less than the enhancement caused by CT in the same experiments. The average Ca 2ϩ current elicited by 5 ng/ml TNP-BSA was Ϫ14.0 Ϯ 1.6 pA in control cells (n ϭ 18), and Ϫ19.9 Ϯ 2.5 pA in cells treated with Sp-cAMPS (n ϭ Figure 3 . CT-enhanced current has I-V characteristics, ionic selectivity, and rapid inactivation typical of I CRAC . (A) Ion substitution experiment on CT-treated cell in which inward current was evoked by TNP-BSA. Upper trace is preinduction current, and lower traces were recorded in 10 mM Ca 2ϩ or 10 mM Ba 2ϩ (plus 1 mM EGTA and no added Ca 2ϩ ). Note that Ba 2ϩ permeates the CT-sensitive pathway and the Ba 2ϩ current rectifies more strongly than does Ca 2ϩ current, as previously shown for antigeninduced I CRAC in control cells (Zhang and McCloskey, 1995) . (B) Antigen-induced Ca 2ϩ current undergoes rapid inactivation to similar degrees in control and CT-treated cells. After induction of Ca 2ϩ current by TNP-BSA (5 ng/ml), voltage steps to Ϫ100 mV were applied from the holding potential of 0 mV. Average traces for three control and three CT-treated cells are shown. Steadystate inactivation at 100 ms was 56 Ϯ 6% in control, and 62 Ϯ 6% in CT-treated cells, an insignificant difference. Perforated-patch recording at 37ЊC for both A and B.
18). In these experiments, CT potentiated antigen-induced I Ca by 2.3-fold. We also tested the effect of another cellpermeant analogue of cAMP, dibutyryl cAMP, which at a concentration of 0.5 mM causes modest potentiation of antigen-induced secretion in RBL-2H3 cells (McCloskey, 1988) . Dibutyryl cAMP at this concentration had no statistically significant effect on antigen-induced I Ca . Thus, chronic elevation of cAMP does not mimic the enhancement of I Ca by CT. Although it is conceivable that CT could amplify a cAMP transient induced by antigen binding, and in this way affect I Ca , previous studies have shown that cross-linkage of the Fc⑀RI does not elevate cAMP in RBL-2H3 cells (Morita and Siraganian, 1981) , and pretreatment with CT does not unmask a latent rise in cAMP (McCloskey, 1988) . Thus, although elevation of cAMP may contribute, it is not the major factor in the large enhancement of antigen-elicted I Ca by CT.
CT Does Not Potentiate I Ca Induced by Thapsigargin or BAPTA
The macroscopic Ca 2ϩ current, I Ca , is directly proportional to the number of Ca 2ϩ channels in the plasma membrane, their unitary conductance, and their probability of being open. Previous findings suggest that in RBL-2H3 cells, the Ca 2ϩ currents associated with both antigen-and thapsigargin-induced Ca 2ϩ influx (Ali et al., 1994) are carried by the same Ca 2ϩ channel (Zhang and McCloskey, 1995) . Thus, if CT were to increase the open probability or unitary conductance of this species, it should potentiate the macroscopic Ca 2ϩ current induced by suboptimal concentrations of thapsigargin, as it does for the antigen-induced current. As demonstrated in Fig. 4 , thapsigargin at 50 pM induced I CRAC equivalent to that induced by suboptimal antigen (1 ng/ml TNP-BSA). Whereas CT enhanced the antigeninduced current by ‫-2.2ف‬fold at 1 ng/ml TNP-BSA, it did not affect the current induced by 50 pM thapsigargin. Indeed, CT did not significantly affect the Ca 2ϩ currents induced by thapsigargin at any concentration tested. This suggests that neither CT nor its substrate Gs, modifies the unitary conductance or open probability of CRAC channels in RBL-2H3 cells.
Thapsigargin presumably activates I CRAC by inhibiting the Ca 2ϩ pumps of the ER (Thastrup et al., 1990 ) and allowing passive leak of stored Ca 2ϩ into the cytosol. In mast cells, I CRAC can also be induced by dialysis of the cell cytoplasm with low Ca 2ϩ pipette solutions buffered with high concentrations of the calcium chelator BAPTA (Fasolato et al., 1993) , conditions which prevent re-uptake of Ca   2ϩ by the ER. We tested the effect of CT on I CRAC induced by dialysis with BAPTA. Cells were preincubated with 2 g/ml CT for 1.5-3 h, then standard whole cell recording was performed at 37ЊC with a Cs glutamate pipette solution containing 10 mM BAPTA ‫03ف(‬ nM free Ca 2ϩ ). CT failed to enhance the Ca 2ϩ current induced by dialysis with BAPTA, just as it had failed to enhance the thapsigargininduced current. The peak current at Ϫ80 mV was Ϫ30 Ϯ 6 pA in control cells (n ϭ 10) and Ϫ28 Ϯ 5 pA in cells pretreated with CT (n ϭ 10). These data provide further evidence that neither CT nor Gs acts directly on the CRAC channels, and they point to the intervention of CT at a step upstream of the channel itself.
Phosphoinositide Hydrolysis and Calcium Release
Because the CT target lies upstream of the Ca 2ϩ channels, a logical candidate is the Ca 2ϩ -releasing messenger, InsP 3 . Augmentation of InsP 3 formation should enhance I CRAC at low antigen levels, but as antigen concentration is increased, a point should be reached at which sufficient InsP 3 is generated to completely release the Ca 2ϩ stores. No further effect of CT on I CRAC induction is expected beyond this concentration of antigen. In principle, this mechanism could explain why CT selectively amplifies antigenbut not thapsigargin-induced I CRAC , because thapsigargin releases stored Ca 2ϩ independent of phosphoinositide hydrolysis. To test this hypothesis we measured antigen-stimulated production of [ 3 H]inositol phosphates (InsPx) in control cells and cells pretreated for 2 h with 2 g/ml CT. InsPx were measured at 200 s after antigen addition, a time which corresponds to the peak Ca 2ϩ current induced by 5 ng/ml TNP-BSA. As indicated in Fig. 5 , at a concentration of TNP-BSA (5 ng/ml) for which CT amplified the induced current by 220%, CT did not significantly affect hydrolysis of [ 3 H]labeled inositol phospholipids. For longer preincubations (5-6 h), CT caused a modest enhancement of antigen-stimulated InsPx production (McCloskey, 1988) . Thus, it appears that CT does not potentiate I CRAC via enhancement of phosphoinositide hydrolysis.
To further test the hypothesis that CT potentiates I CRAC by accentuating antigen-induced Ca 2ϩ release, we measured cytosolic free calcium after stimulation of IgE-sensitized RBL-2H3 cells with antigen. Cells were pretreated or not with 2 g/ml Ϫ1 CT for 1 h, loaded with 2 M fura-2 AM for 30 min, kept for another 30 min at 37ЊC, and then stimulated with 5 ng/ml Ϫ1 TNP-BSA on the stage of the microscope. Cells were plated at the same low density as during patch clamping, which limited the average number ] i peaks were aligned as described in Materials and Methods. The corresponding plots as shown in Fig. 6 show no statistically significant difference between the peak heights or the rate of decline in [Ca 2ϩ ] i in control and CT-treated cells. By these criteria, it does not appear that the ability of CT to double antigen-evoked I CRAC is due to enhanced Ca 2ϩ release from internal compartments.
Effects of BFA on Ca 2ϩ Current
In addition to their cell surface localization, some heterotrimeric G proteins, including Gs, are located on intracellular membranes, where they regulate vesicle trafficking (Helms, 1995) . CT enhances transcytosis of vesicles containing the poly Ig receptor as well as the apical transport of influenza hemagglutinin (Bomsel and Mostov, 1993; Pimplikar and Simons, 1993) . Conceivably, CT affects the trafficking of vesicles, including those bearing CRAC channels, to or from the plasma membrane of RBL-2H3 cells. To test this hypothesis, we examined the effects of BFA on CT-enhanced I Ca . BFA is a fungal metabolite that inhibits certain vesicle transport and fusion steps by inhibiting GTP/guanosine diphosphate exchange on ARF proteins, thereby blocking their association with membranes (Klausner et al., 1992; Randazzo et al., 1993) . Cells were preincubated with BFA, CT, or BFA plus CT for 1.5-3 h, and voltage-clamp measurements performed after patch permeabilization. BFA was present throughout the nystatin permeabilization and recording periods. At a concentration (2 g/ml) that had no significant effect on I Ca induced by suboptimal antigen (5 ng/ml TNP-BSA), BFA reduced by 84% the enhancement of I Ca by CT (Fig. 7) . This implicates the involvement of ARF in the enhancement of I CRAC by CT. We next determined whether BFA reduced the enhancement of I Ca through blocking the ADP ribosylation of Gs␣, rather than by modulating a function of Gs so modified. This is an important question because BFA prevents the membrane association of ARF proteins, which can enhance ADP ribosylation of Gs␣ in vitro (Kahn and Gilman, 1986) . We examined the effect of BFA on ADP ribosylation of endogenous Gs␣ by assaying the CT-mediated [
32 P]ADP ribosylation of Gs in membrane preparations. Cells were pretreated with 2 g/ml CT in the presence or the absence of 2 g/ml BFA. Membranes from control and CT-treated cells were then isolated and treated with activated CT and 32 P-NAD. Fig. 8 shows that pretreatment of cells with CT (Fig. 8, lane D) prevented the subsequent transfer of [ 32 P]ADP ribosyl moieties to Gs␣, presumably because the acceptor arginine residue in Gs␣ was already substituted with nonradioactive ADP ribose from endogenous NAD. If BFA were to prevent this reaction in intact cells, then incubation of cells with both CT and BFA before membrane isolation should cause the reappearance of a radioactive band in the gel after in vitro treatment with radioactive NAD and activated CT. However, as shown in Fig. 8 , lanes C and E, the presence of BFA at 2 g/ml did not interfere with ADP ribosylation either in vitro (Fig. 8, lane C) or in intact cells (Fig. 8, lane  E) . Thus, the inhibition by BFA of CT-enhanced I CRAC is not an artifact of reduced ADP ribosylation of the CT substrate, Gs.
Could the differential effect of CT at low vs. high antigen levels indicate a progressively greater contribution of an ARF-mediated event with increase in antigen concentration? At a concentration of TNP-BSA (500 ng/ml) that induced the maximal Ca 2ϩ current, BFA substantially inhibited the induction. In these experiments cells were preincubated with 2 g/ml BFA for 1 h at 37ЊC before patch clamping, and they were also exposed to the drug during the permeabilization and induction periods. In measurements performed on 5-d cultures, the magnitude of I Ca was Ϫ61.7 Ϯ 6.6 pA (n ϭ 12), whereas in BFA-treated cells, the peak I Ca was Ϫ45.6 Ϯ 4.9 pA (n ϭ 14). In 4-d cultures, 500 ng/ml TNP-BSA induced I Ca of Ϫ46.8 Ϯ 2.2 pA (n ϭ 5) in control, and Ϫ35.8 Ϯ 4.3 pA (n ϭ 5) in BFA-treated cells. Thus, BFA inhibited the induction of CRAC currents ‫%03ف‬ for both 4-and 5-d cultures, although at this sample size the difference is barely significant at P ϭ 0.05.
In contrast, BFA did not affect I Ca induced by thapsigargin. The average current induced by 100 nM thapsigargin was Ϫ38.9 Ϯ 5.9 pA (n ϭ 10) in control cells, and Ϫ38.9 Ϯ 5.5 pA (n ϭ 10) in cells pretreated for 1.5-2.5 h with 2 g/ml BFA. These findings suggest that the Fc⑀RI activates I CRAC through means in addition to Ca 2ϩ store depletion, and that BFA and CT affect a step unique to the antigeninduced pathway to I CRAC . But if so, why were the maximal Ca 2ϩ currents induced by thapsigargin and antigen similar? One clue comes from preliminary experiments on the effect of thapsigargin added after maximal induction of I CRAC by antigen. Thapsigargin induced a Ca 2ϩ current of Ϫ46 Ϯ 3 pA (n ϭ 6) in cells stimulated previously with optimal antigen (500 or 5000 ng/ml TNP-BSA), a 44% increase over the initial antigen-induced current in the same cells, and 21% greater than the thapsigargin-induced current in antigen-naive cells. Thus, the antigen-stimulated cells might contain a greater number of CRAC channels with a lower open probability than those in thapsigarginstimulated cells. The latter would not be surprising, given that I CRAC in RBL-2H3 cells is desensitized by protein kinase C-dependent phosphorylation (Penner et al., 1986) , and this enzyme could be more active in antigen-than thapsigargin-treated cells. Moreover, thapsigargin irreversibly depletes the Ca 2ϩ stores, whereas antigen causes an oscillatory Ca 2ϩ signal that requires InsP 3 , to which the InsP 3 receptor becomes desensitized.
Discussion
Other than a role for Ca 2ϩ store depletion, the molecular mechanisms that regulate antigen-stimulated Ca 2ϩ influx into mast cells are not well-understood. The observation that CT dramatically enhances 45 Ca 2ϩ influx into RBL-2H3 cells suggests that this reagent might be a useful tool to study the Ca 2ϩ entry pathway (Narasimhan et al., 1988) . That CT amplifies both antigen-evoked I CRAC and 45 Ca 2ϩ influx to a similar extent bolsters the idea that CRAC channels are a major pathway for Fc⑀RI-mediated Ca 2ϩ uptake into RBL-2H3 mast cells (Zhang and McCloskey, 1995) . Two hypotheses to explain the effect of CT on 45 Ca 2ϩ influx are immediately testable by patch clamping. First, it is possible that CT activates Cl Ϫ or K ϩ channels, and thereby increases the electrical force propelling Ca 2ϩ entry. This indirect mechanism cannot explain the enhancement of Ca 2ϩ influx currents that we observed, because voltage-clamp measurements eliminate any difference in membrane potential between control and CT-treated cells. Second, Gs might bind directly to CRAC channels and increase their open probability, as occurs with voltage- Figure 7 . BFA inhibits the enhancement of antigen-induced I Ca by CT. Simultaneous treatment with 2 g/ml BFA and 2 g/ml CT blocks by 84% the enhancement of antigen-elicited I Ca by CT, whereas magnitude of Ca 2ϩ current induced by suboptimal antigen alone or by optimal thapsigargin was not affected. Currents were measured using perforated patch recording at 37ЊC, using a TNP-BSA concentration of 5 ng/ml and a thapsigargin concentration of 100 nM. Black bars, control cells; gray bars, cells treated with BFA. Numbers inside bars give sample size. dependent Ca 2ϩ channels (Hamilton et al., 1991) . This mechanism is no longer tenable, as CT did not affect the CRAC currents elicited by BAPTA or thapsigargin (at concentrations inducing submaximal or maximal I Ca ). Although the negative result with BAPTA could be due to loss of critical cytosolic factors during conventional whole cell recording, this is not true for the induction by thapsigargin during perforated-patch recording, nor can reduced rates of fast or slow inactivation explain the amplified I CRAC .
CT by itself does not provide all signals required to activate I CRAC . Rather, it appears to amplify a signal unique to the Fc⑀RI-initiated pathway for induction of I CRAC , somewhere upstream of the channels themselves. An obvious candidate for the site of intervention is the formation of Ca 2ϩ -releasing second messengers. As shown in Fig. 5 , at a concentration of antigen at which CT enhanced I CRAC by 2.2-fold, CT did not affect antigen-stimulated phosphoinositide hydrolysis. As observed previously, prolonged incubation (6 h) with CT significantly enhanced inositol phosphates production, but this preincubation was much longer than that required for I CRAC enhancement (McCloskey, 1988 ). In addition, others have reported that CT does not affect the Fc⑀RI-linked production of inositol-1,4,5-trisphosphate per se (Narasimhan et al., 1988) . In any case, we found that neither the rate of Ca 2ϩ release nor the peak Ca 2ϩ rise was greater in CT-treated than control cells, suggesting that the ability of CT to double antigen-induced I CRAC is not due to enhanced Ca 2ϩ release. ARF is a monomeric GTPase that interacts with the CT-A subunit to enhance ADP ribosylation of Gs␣ (Kahn and Gilman, 1986) . Six members of the ARF family are currently recognized, each of which reversibly associates with membranous organelles (Hosaka et al., 1996) . In their GTP-bound state, ARF proteins activate phospholipase D (Brown et al., 1993; Cockcroft et al., 1994) and promote the assembly of protein coats that mediate vesicle budding and transport (for reviews see Donaldson and Klausner, 1994; Boman and Kahn, 1995; Moss and Vaughn, 1998) . ARF binds to both Gs and CT-A in vitro (Boman and Kahn, 1995; Colombo et al., 1995) , and it is possible that either interaction might perturb ARF function in cellulo. Together with ARF, Gs is present on the TGN, where it regulates vesicle budding (for review see Helms, 1995) . These observations suggest that CT might enhance I CRAC by modulating ARF activity. We tested this idea with BFA, a fungal metabolite that prevents membrane association of ARF and inhibits ARF-dependent functions (Klausner et al., 1992) . That BFA strongly inhibited the enhancement of I CRAC by CT, and in preliminary experiments partially inhibited the induction of I CRAC by optimal antigen, suggests that ARF proteins may participate in the induction of I CRAC by antigen.
Further studies are necessary to confirm this idea, but it is tempting to speculate that the Fc⑀RI, through means in addition to Ca 2ϩ store depletion, somehow modulates an ARF function that controls CRAC channel activity. Interestingly, cross-linkage of the Fc⑀RI in RBL-2H3 cells inhibits redistribution of ARF and ␤-COP from Golgi membranes to the cytosol after cell permeabilization (De Matteis et al., 1993) . Cross-linkage of Fc⑀RI also increases the rate of vesicular transport of 35 S-labeled proteoglycans from distal Golgi compartments to the plasma membrane, a putative ARF-dependent process (Buccione et al., 1996) .
If CT amplifies a signal linking the Fc⑀RI to ARF, how could this enhance I CRAC ? One possibility stems from the observation that pretreatment of PC12 cells with CT enhances the cell-free formation of both constitutive secretory vesicles and immature secretory granules from the TGN (Leyte et al., 1992) . In MDCK epithelial cells, CT acts via Gs to stimulate transcytosis of occupied poly-Ig receptors and increase apical transport of vesicles bearing influenza hemagglutinin (Bomsel and Mostov, 1993; Pimplikar and Simons, 1993) . Activation of Gs with CT also inhibits endosome fusion in J774 macrophages, a process thought to involve ARF (Colombo et al., 1994) . The ARFdirected reagent BFA inhibits so-called constitutive secretion as well as insulin-triggered exocytosis of vesicles bearing the GLUT4 glucose transporter in rat adipocytes (Lachaal et al., 1994) , Ca 2ϩ -induced exocytosis of secretory granules in melanotrophs (Rupnik et al., 1995) , cAMP-induced delivery of the cystic fibrosis transmembrane conductance regulator to the surface of human airway epithelial cells (Schwiebert et al., 1994) , and recycling of transferrin receptors to the cell surface of K562 cells (Schonhorn and Wessling-Resnick, 1994) . Further studies are necessary to determine whether ARF, through vesicle transport or other means, participates in the induction of I CRAC via the Fc⑀RI.
In summary, the potentiation of I CRAC by CT does not result from direct modification of CRAC channel properties by Gs or CT. Nor is it an indirect result of membrane hyperpolarization or reduced rates of I CRAC inactivation. The effect is restricted to antigen-induced I CRAC , and the site of intervention apparently lies upstream of the CRAC channels themselves. It appears to be independent of phosphoinositide hydrolysis or the rate of Ca 2ϩ release. Although other interpretations are tenable, the data suggest that Fc⑀RI may act via ARF to enhance surface CRAC channel activity.
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